Dhanvantri Jeevan Rekha Ltd Stock Price Today (NSE: ZDHJERK)
Fundamental Score
Dhanvantri Jeevan Rekha Ltd Share Price Live NSE/BSE & Institutional Fundamental Analysis
Dhanvantri Jeevan Rekha Ltd share price today is ₹24.28, up +0.00% on NSE/BSE as of 17 February 2026. Dhanvantri Jeevan Rekha Ltd (ZDHJERK) is a Small-cap company in the Healthcare Service Provider sector with a market capitalisation of ₹9.45 (Cr). The 52-week high for ZDHJERK share price is ₹N/A and the 52-week low is ₹N/A. At a P/E ratio of 94.50x, ZDHJERK is currently trading above its industry average P/E of 39.28x. The company has a Return on Equity (ROE) of 5.20% and a debt-to-equity ratio of 0.00.
Dhanvantri Jeevan Rekha Ltd Share Price Chart — NSE/BSE Historical Performance
Returns & Performance
ROE
ROCE
OPM (5Y)
Div Yield
Dhanvantri Jeevan Rekha Ltd Valuation Check
P/E Ratio
Industry P/E
Market Cap
Growth Engine
Profit Growth (Q)
Sales Growth (Q)
Sales Growth (5Y)
EPS Growth (5Y)
Profit Growth (5Y)
Balance Sheet Health
Debt to Equity
Int. Coverage
Free Cash Flow (5Y)
Shareholding
Promoter
FII
DII
Pledged
Institutional Deep-Dive
Bull Run Research Hub
Dhanvantri Jeevan Rekha Share Price: A Financial Analysis
The healthcare service provider landscape is shifting, with increasing demand for accessible and affordable diagnostics. Analyzing the Dhanvantri Jeevan Rekha share price reveals several critical factors that influence its valuation. Currently trading at ₹24.899999618530273, and with a PE ratio of 94.5, Dhanvantri Jeevan Rekha Ltd appears potentially overvalued compared to the broader market. However, a deeper dive into its fundamentals is necessary to ascertain its true investment potential.
One of the key metrics to assess is the Return on Capital Employed (ROCE), which currently stands at 5.82%. This indicates the efficiency with which the company is generating profits from its capital. A lower ROCE, relative to its cost of capital, suggests a limited economic moat. In other words, it might be challenging for Dhanvantri Jeevan Rekha Ltd to sustain profitability and fend off competition in the long run. This needs to be considered in context of the broader diagnostic market. A low ROCE impacts the company’s ability to re-invest earnings at a high rate to increase its dominance.
Comparing Dhanvantri Jeevan Rekha Ltd to its peers offers further insight. For example, consider
Suraksha Diagnostic Ltd. Suraksha Diagnostic Ltd., might exhibit contrasting management qualities or strategies impacting overall company performance. While we aren’t making specific claims about Suraksha Diagnostic Ltd.'s management, differences in management quality can translate to variations in operational efficiency and ultimately, stock performance. Investors should closely examine the leadership and strategic direction of both companies. Aspira Pathlab & Diagnostics Limited and Gian Life Care Ltd offer similar comparison points.In conclusion, assessing the long-term viability of Dhanvantri Jeevan Rekha requires scrutiny of its financial performance, its competitive positioning within the healthcare diagnostics sector, and its ability to improve its ROCE. This analysis is based on observable data and is part of a comprehensive 80-parameter fundamental audit verified by Sweta Mishra. This is not investment advice, and further due diligence is advised.
Labels (e.g., "Excellent", "Good") are peer-based vs industry/sector averages — data-only, not advice
Dhanvantri Jeevan Rekha Ltd Fundamental Analysis & Valuation Benchmarking
Educational evaluation of ZDHJERK across key market metrics for learning purposes.
Positive Indicators
4 factors identified
Excellent EPS Growth (31.70% CAGR)
Observation: Outstanding 5-year earnings per share compound growth.
Analysis: EPS CAGR >15% indicates strong wealth creation potential.
Strong Profit Growth Track Record (31.70% CAGR)
Observation: Consistent 5-year profit compound annual growth rate.
Analysis: Profit CAGR >15% demonstrates scalable business model.
Debt-Free Balance Sheet (D/E: 0.00)
Observation: Low leverage provides financial flexibility and reduced risk.
Analysis: Conservative debt structure offers resilience during economic downturns.
Zero Share Pledging Risk
Observation: No promoter shares pledged as collateral.
Analysis: Absence of share pledging eliminates potential forced-selling pressure.
Risk Factors
8 factors identified
Below-Average Return on Equity (5.20%)
Observation: Returns on equity are below industry benchmarks.
Analysis: ROE <10% may indicate inefficient capital utilization. Consider monitoring for operational improvements and management effectiveness.
Suboptimal ROCE (5.82%)
Observation: Returns on capital employed are below expectations.
Analysis: ROCE <10% suggests potential inefficiencies in capital allocation.
Margin Pressure Concerns (3.31%)
Observation: Operating margins are below industry standards.
Analysis: OPM <5% may indicate pricing pressures or cost management challenges.
Premium Valuation Risk (P/E: 94.50x)
Observation: High valuation multiples may limit upside potential.
Analysis: Elevated P/E ratios require strong growth execution to justify current valuations.
Profit Decline Concern (-182.35%)
Observation: Significant year-over-year profit contraction observed.
Analysis: Declining profitability requires investigation into underlying causes.
Limited Growth History (4.46% CAGR)
Observation: Below-average 5-year sales growth trajectory.
Analysis: Low sales CAGR may indicate mature markets or limited growth opportunities.
Low Promoter Commitment (19.65%)
Observation: Reduced promoter stake may indicate limited confidence.
Analysis: Low promoter holding may raise questions about management commitment.
No Dividend Distribution
Observation: Company does not currently pay dividends to shareholders.
Analysis: Zero dividend yield may indicate growth reinvestment focus or cash flow constraints.
Dhanvantri Jeevan Rekha Ltd Financial Statements
Comprehensive financial data for Dhanvantri Jeevan Rekha Ltd including income statement, balance sheet and cash flow
About ZDHJERK (Dhanvantri Jeevan Rekha Ltd)
Dhanvantri Jeevan Rekha Ltd (ZDHJERK) is listed on the National Stock Exchange (NSE) and Bombay Stock Exchange (BSE) of India. The company operates in the Healthcare Service Provider sector with a current market capitalisation of ₹9.45 (Cr). Dhanvantri Jeevan Rekha Ltd has delivered a Return on Equity (ROE) of 5.20% and a ROCE of 5.82%. The debt-to-equity ratio stands at 0.00, reflecting the company's capital structure. Investors tracking ZDHJERK share price can monitor key metrics including P/E ratio, promoter holding of 19.65%, and quarterly earnings growth.
Company Details
Key Leadership
Corporate Events
ZDHJERK Share Price: Frequently Asked Questions
What is the current share price of Dhanvantri Jeevan Rekha Ltd (ZDHJERK)?
As of 17 Feb 2026, 09:30 am IST, Dhanvantri Jeevan Rekha Ltd share price is ₹24.28. The ZDHJERK stock has a market capitalisation of ₹9.45 (Cr) on NSE/BSE.
Is ZDHJERK share price Overvalued or Undervalued?
ZDHJERK share price is currently trading at a P/E ratio of 94.50x, compared to the industry average of 39.28x. Based on this relative valuation, the Dhanvantri Jeevan Rekha Ltd stock appears to be Overvalued against its sector peers.
What is the 52-week high and low of ZDHJERK share price?
The 52-week high of ZDHJERK share price is ₹N/A and the 52-week low is ₹N/A.
What factors affect the Dhanvantri Jeevan Rekha Ltd share price?
Key factors influencing ZDHJERK share price include quarterly earnings growth (Sales Growth: 7.75%), raw material costs, government infrastructure spending, and institutional flows (FII/DII holding).
Is Dhanvantri Jeevan Rekha Ltd a good stock for long-term investment?
Dhanvantri Jeevan Rekha Ltd shows a 5-year Profit Growth of 31.70% and an ROE of 5.20%. Long-term investors should consider these fundamentals alongside the debt-to-equity ratio of 0.00 before investing in ZDHJERK shares.
How does Dhanvantri Jeevan Rekha Ltd compare with its industry peers?
Dhanvantri Jeevan Rekha Ltd competes with major peers in the Healthcare Service Provider. Investors should compare ZDHJERK share price P/E of 94.50x and ROE of 5.20% against the industry averages to determine competitive standing.
What is the P/E ratio of ZDHJERK and what does it mean?
ZDHJERK share price has a P/E ratio of 94.50x compared to the industry average of 39.28x. Investors pay ₹95 for every ₹1 of annual earnings.
How is ZDHJERK performing according to Bull Run's analysis?
ZDHJERK has a Bull Run fundamental score of 23.9/100, indicating concerns requiring careful analysis. This comprehensive rating is based on 15+ financial parameters.
What sector and industry does ZDHJERK belong to?
ZDHJERK operates in the Healthcare Service Provider industry. This classification helps understand the competitive landscape and sector-specific trends affecting Dhanvantri Jeevan Rekha Ltd share price.
What is Return on Equity (ROE) and why is it important for ZDHJERK?
ZDHJERK has an ROE of 5.20%, which suggests challenges in generating returns from shareholders equity. ROE measures how efficiently Dhanvantri Jeevan Rekha Ltd generates profits from shareholders capital.
How is ZDHJERK debt-to-equity ratio and what does it indicate?
ZDHJERK has a debt-to-equity ratio of 0.00, which indicates conservative financing with low financial risk.
What is ZDHJERK dividend yield and is it a good dividend stock?
ZDHJERK offers a dividend yield of 0.00%, meaning you receive ₹0.00 annual dividend for every ₹100 invested in Dhanvantri Jeevan Rekha Ltd shares.
How has ZDHJERK share price grown over the past 5 years?
ZDHJERK has achieved 5-year growth rates of: Sales Growth 4.46%, Profit Growth 31.70%, and EPS Growth 31.70%.
What is the promoter holding in ZDHJERK and why does it matter?
Promoters hold 19.65% of ZDHJERK shares, with 0.00% pledged. High promoter holding often indicates strong management confidence in Dhanvantri Jeevan Rekha Ltd.
What is ZDHJERK market capitalisation category?
ZDHJERK has a market capitalisation of ₹9 crores, placing it in the Small-cap category.
How volatile is ZDHJERK stock?
ZDHJERK has a beta of N/A. A beta > 1 suggests the Dhanvantri Jeevan Rekha Ltd stock is more volatile than the market, while a beta < 1 suggests it is less volatile.
What is ZDHJERK operating profit margin trend?
ZDHJERK has a 5-year average Operating Profit Margin (OPM) of 3.31%, indicating the company's operational efficiency.
How is ZDHJERK quarterly performance?
Recent quarterly performance shows Dhanvantri Jeevan Rekha Ltd YoY Sales Growth of 7.75% and YoY Profit Growth of -182.35%.
What is the institutional holding pattern in ZDHJERK?
ZDHJERK has FII holding of 0.00% and DII holding of 0.00%. Significant institutional holding often suggests professional confidence in the Dhanvantri Jeevan Rekha Ltd stock.